Pharming Group N.V. (PHAR) stock
PHARNasdaqPharmaceutical PreparationsFiscal year ends December 31
$12.06−0.53 (-4.21%)
Close on Nov 17, 2026Market cap $846.23MP/E 301.5Yield –
Pharming revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2025 it was $376.13M, up 26.6% from the year before. The highest annual figure on record is $376.13M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $376.13M | +26.6% |
| FY2024 | Dec 31, 2024 | $297.20M | +21.1% |
| FY2023 | Dec 31, 2023 | $245.32M | +19.3% |
| FY2022 | Dec 31, 2022 | $205.62M | +3.4% |
| FY2021 | Dec 31, 2021 | $198.87M | -6.3% |
| FY2020 | Dec 31, 2020 | $212.17M | +12.0% |
| FY2019 | Dec 31, 2019 | $189.39M | – |
See a number that looks wrong?